ATRC AtriCure Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ATRC

Price (delayed)

$23.05

Market cap

$1.1B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.66

Enterprise value

$1.09B

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure ...

Highlights
The company's gross profit rose by 22% YoY and by 5% QoQ
ATRC's revenue is up by 21% year-on-year and by 4.9% since the previous quarter
AtriCure's EPS has increased by 35% YoY but it has decreased by 22% from the previous quarter
ATRC's net income is up by 34% YoY but it is down by 23% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.atricure.com
Peers: TFX EW BSX COO

Key stats

What are the main financial stats of ATRC
Market
Shares outstanding
47.59M
Market cap
$1.1B
Enterprise value
$1.09B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.34
Price to sales (P/S)
2.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.72
Earnings
Revenue
$399.25M
EBIT
-$22.92M
EBITDA
-$8.11M
Free cash flow
-$37.51M
Per share
EPS
-$0.66
Free cash flow per share
-$0.81
Book value per share
$9.84
Revenue per share
$8.62
TBVPS
$6.81
Balance sheet
Total assets
$613.93M
Total liabilities
$147.76M
Debt
$74.49M
Equity
$466.17M
Working capital
$191.68M
Liquidity
Debt to equity
0.16
Current ratio
3.57
Quick ratio
2.55
Net debt/EBITDA
1.21
Margins
EBITDA margin
-2%
Gross margin
75.2%
Net margin
-7.6%
Operating margin
-6.7%
Efficiency
Return on assets
-5.1%
Return on equity
-6.6%
Return on invested capital
-10%
Return on capital employed
-4.2%
Return on sales
-5.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATRC stock price

How has the AtriCure stock price performed over time
Intraday
-0.52%
1 week
-1.71%
1 month
-19.04%
1 year
-44.31%
YTD
-35.42%
QTD
-24.23%

Financial performance

How have AtriCure's revenue and profit performed over time
Revenue
$399.25M
Gross profit
$300.37M
Operating income
-$26.68M
Net income
-$30.44M
Gross margin
75.2%
Net margin
-7.6%
The operating margin has grown by 48% year-on-year but it has declined by 16% since the previous quarter
The net margin has grown by 46% YoY but it has contracted by 17% from the previous quarter
The operating income has increased by 37% YoY but it has decreased by 20% from the previous quarter
ATRC's net income is up by 34% YoY but it is down by 23% QoQ

Growth

What is AtriCure's growth rate over time

Valuation

What is AtriCure stock price valuation
P/E
N/A
P/B
2.34
P/S
2.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.72
AtriCure's EPS has increased by 35% YoY but it has decreased by 22% from the previous quarter
ATRC's price to book (P/B) is 56% lower than its 5-year quarterly average of 5.3 and 46% lower than its last 4 quarters average of 4.3
The equity has grown by 2.1% YoY
ATRC's P/S is 66% below its 5-year quarterly average of 7.9 and 50% below its last 4 quarters average of 5.3
ATRC's revenue is up by 21% year-on-year and by 4.9% since the previous quarter

Efficiency

How efficient is AtriCure business performance
AtriCure's ROS has soared by 54% YoY but it has decreased by 21% from the previous quarter
AtriCure's return on assets has increased by 35% YoY but it has decreased by 21% QoQ
The ROE has grown by 35% YoY but it has contracted by 22% from the previous quarter
The company's return on invested capital fell by 33% QoQ but it rose by 32% YoY

Dividends

What is ATRC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRC.

Financial health

How did AtriCure financials performed over time
The current ratio is up by 17% since the previous quarter but it has declined by 3.3% year-on-year
The total liabilities has grown by 15% year-on-year and by 8% since the previous quarter
The debt is 84% less than the equity
The equity has grown by 2.1% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.